Transaction #27037 · Form 4 · 0001683168-26-000016
CNS Pharmaceuticals, Inc. · Stock award · Restricted Stock Units
CNS Pharmaceuticals, Inc. · Transacted January 1, 2026 · Filed January 2, 2026
What does this filing report?
An SEC Form 4 filing for CNS Pharmaceuticals, Inc. records a stock award involving Restricted Stock Units on January 1, 2026. The reported quantity was 19,000. The filing date is January 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CNS Pharmaceuticals, Inc.
- Company CIK
- 0001729427
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 19,000
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 19,000
- Ownership description
- Not reported
- SEC acceptance time
- Jan 2, 2026, 5:01 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Levin Rami ↗
CEO and President · Director
CIK 0002102719
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 19,000
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- January 1, 2036
Filing footnotes & remarks
- F1
- Each restricted stock unit represents a contingent right to receive one share of Company common stock.
- F2
- The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.
- F3
- Issued in connection with the reporting person's employment with the Company.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.